114
Participants
Start Date
December 3, 2009
Primary Completion Date
September 13, 2012
Study Completion Date
April 16, 2013
Cinacalcet
Possible sequential doses are 30, 60, 90, 120, and 180 mg.
Placebo
Administered orally following the same dosing regimen as the experimental arm.
Research Site, Vienna
Research Site, Brussels
Research Site, Geneva
Research Site, Camperdown
Research Site, Westmead
Research Site, Leuven
Research Site, Bern
Research Site, Parkville
Research Site, Woodville South
Research Site, Zurich
Research Site, Ghent
Research Site, New York
Research Site, Berlin
Research Site, Genova
Research Site, Bethlehem
Research Site, Milan
Research Site, Kiel
Research Site, Madrid
Research Site, Málaga
Research Site, Atlanta
Research Site, Toulouse
Research Site, Gainesville
Research Site, Bordeaux
Research Site, Montpellier
Research Site, Padua
Research Site, Nashville
Research Site, Nantes
Research Site, Detroit
Research Site, Evanston
Research Site, Chicago
Research Site, Dallas
Research Site, Paris
Research Site, Houston
Research Site, Aurora
Research Site, Phoenix
Research Site, Tempe
Research Site, San Francisco
Research Site, Springfield
Research Site, Calgary
Research Site, Vancouver
Research Site, London
Research Site, Ottawa
Research Site, Toronto
Research Site, Gdansk
Research Site, Katowice
Research Site, Lodz
Research Site, Poznan
Research Site, Szczecin
Research Site, Barcelona
Research Site, Barcelona
Research Site, L'Hospitalet de Llobregat
Lead Sponsor
Amgen
INDUSTRY